{"version":"1.0","provider_name":"Brakke Consulting\u306e\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8","provider_url":"https:\/\/brakkeconsulting.com\/ja","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"SCL9bSVwBc\"><a href=\"https:\/\/brakkeconsulting.com\/ja\/animal-health-news-notes-for-october-8-2021\/\">2021 \u5e74 10 \u6708 8 \u65e5\u306e\u52d5\u7269\u306e\u5065\u5eb7\u306b\u95a2\u3059\u308b\u30cb\u30e5\u30fc\u30b9\u3068\u30ce\u30fc\u30c8<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/ja\/animal-health-news-notes-for-october-8-2021\/embed\/#?secret=SCL9bSVwBc\" width=\"600\" height=\"338\" title=\"&#8220;Animal Health News &#038; Notes for October 8, 2021&#8221; &#8212; Brakke Consulting Website\" data-secret=\"SCL9bSVwBc\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"*********************************** Brakke Consulting&#8217;s Animal Health News &amp; Notes for October 8, 2021 Copyright \u00a9 Brakke Consulting Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: Other News AB Vista AniV8 Anpario Avivagen BetterVet Boehringer Ingelheim Elanco Embark Veterinary EquiTrace Feedworks USA Fromm Family Foods Fulfillment Advantage Ventures HBAN Irrus Investments Medgene Labs Newport Laboratories Pro-Vet Pulse Veterinary Technologies Smart Tracking Technologies Stonehaven Incubate Swedencare Vaxxinova VetPrep Zinpro Zoetis (facility expansion) Zoetis (VetScan Imagyst) Zomedica Corp ************************************ COMPANY NEWS RELEASES Zoetis announced it is supporting growing demand for its monoclonal antibodies &#8211; Cytopoint, Solensia and Librela &#8211; by increasing its production capacity in Tullamore, Ireland. The firm expects construction to commence in early 2022, with the expanded facility scheduled to become fully operational by 2025. Zoetis is also expanding its manufacturing site in Nebraska to support the global commercial reach of Librela. (IHS Markit Connect) Zoetis announced the addition of digital cytology testing to the Vetscan Imagyst multi-purpose diagnostics technology platform. With this innovation, Vetscan Imagyst now employs a network of expert remote pathologists along with artificial intelligence (AI) technology for fecal testing. (DVM360) Elanco Animal Health announced that it plans to carve out its microbiome research-and-development platform as it sharpens its focus on its late-stage pet-health pipeline. The company said the move would create a privately funded, independent biopharmaceutical companyView Full Post;","thumbnail_url":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2021\/10\/Stock-Table-10.7.jpg"}